Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -7.35M | -154.74% | $ 4.75M |
3/31/2025 | $ -4.94M | -69.08% | $ 7.15M |
12/31/2024 | $ -5.19M | -53.05% | $ 9.78M |
9/30/2024 | $ -4.53M | -40.48% | $ 11.2M |
6/30/2024 | $ -2.83M | -23.58% | $ 12.02M |
3/31/2024 | $ -4.1M | -28.81% | $ 14.23M |
12/31/2023 | $ -4.15M | -28.18% | $ 14.73M |
9/30/2023 | $ -5.04M | -34.44% | $ 14.64M |
6/30/2023 | $ -6.45M | -42.41% | $ 15.2M |
3/31/2023 | $ -6.31M | -46.26% | $ 13.64M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for NOVABAY PHARMACEUTICALS INC is calculated as follows: FCF [ $ -4.71M ] / Revenues [ $ 9.75M ]
(=) FCF % [ -48.31% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |